
Sign up to save your podcasts
Or


In this episode, we challenge conventional prescribing by exploring why lithium should be the first-line treatment for acute classic mania, despite widespread use of antipsychotics. Dr. David Osser presents evidence-based arguments for lithium's unique neuroprotective benefits and long-term efficacy.
Faculty: David Osser, M.D. Host: Richard Seeber, M.D.
By Psychopharmacology Institute4.6
269269 ratings
In this episode, we challenge conventional prescribing by exploring why lithium should be the first-line treatment for acute classic mania, despite widespread use of antipsychotics. Dr. David Osser presents evidence-based arguments for lithium's unique neuroprotective benefits and long-term efficacy.
Faculty: David Osser, M.D. Host: Richard Seeber, M.D.

1,327 Listeners

75 Listeners

499 Listeners

145 Listeners

3,349 Listeners

161 Listeners

1,347 Listeners

732 Listeners

561 Listeners

472 Listeners

461 Listeners

732 Listeners

190 Listeners

152 Listeners

123 Listeners